NIH supports Cellular Senescence Network centers to discover and validate cellular senescence signatures and biomarkers and study their roles in health and disease; clinical trials are not allowed.
NIH funding supports a Stage 2 Cellular Senescence Network center to coordinate, integrate, and share data, maintain data infrastructure, and organize consortium outreach; clinical trials are not allowed.
NIH offers five-year, milestone-driven awards to develop and validate technologies for studying senescent cell diversity and its effects on aging and disease; clinical trials are not allowed.
NIH funds centers to systematically test how genomic variants affect genome function and phenotypes, develop reproducible data pipelines, and collaborate in a consortium; clinical trials are not allowed.
This grant will fund a center to coordinate patient support, data management, research, and collaboration for advancing diagnosis and care of individuals with undiagnosed diseases through the Undiagnosed Diseases Network.
The NCI plans to fund research projects using systems-level approaches to study metastasis within its Metastasis Research Network, with applications expected in Fall 2025.